
Explore our infrastructure
At SciLifeLab, we provide access to a range of pioneering technologies in molecular biosciences. Together, our capabilities enable the scientific endeavours of users from academia, industry and health care. Dedicated staff scientists can offer support throughout the experimental process – from study design to data handling.
Capabilities
The foundation of SciLifeLab rests on three pillars: state of the art research infrastructure, a community of world-class researchers, and an extensive Data-Driven Life Science program (DDLS).
News highlights
Research at SciLifeLab
At SciLifeLab, no research group is an island. We live by collaboration and gather scientists in a broad range of molecular bioscience research, from health to environmental research, in order to facilitate multidisciplinary studies and networking.
A number of research constellations and initiatives makes up our scientific community, such as the more than 200 affiliated academic research groups, the SciLifeLab Fellows program, Data-driven life science, and lately also a national research program targeting Covid-19.
There’s a truly symbiotic relationship existing with our infrastructure. Our units provide access to the latest biomolecular technologies and expertise to bring research projects to the next level, whilst researchers using our services can team up with our dedicated staff scientists to propel technology development and really push the limit of what is possible in life science.
Upcoming events
Imaging in Cell and Molecular Biology
Mar 17 – 18 12:00 – 15:00
Ångström Laboratory
Imaging in Cell and Molecular Biology
The DDLS research area symposia series aims to engage and build a strong national scientific community around the DDLS research themes. Each of the four areas arranges two symposia per year. […]
PULSE Challenge: Selection and screening of antibody based drugs
This presentation will provide an overview of the selection and screening processes, as well as future challenges for antibody-based drugs. It will be exemplified with data from one of Alligator Bioscience’s bispecific antibody drug candidates, ATOR-4066.
Advancing biomarker discovery with innovative omics technologies
Takara Bio Europe, in collaboration with Clinical Genomics Gothenburg, invites you to explore their latest NGS technologies, enjoy insightful talks from guest speakers, and discover how their innovations are driving cutting-edge research! Agenda and speakers […]
DDLS Research School Annual Meeting
The first DDLS Research School Annual Meeting for PhDs and PIs, including DDLS fellows. This meeting is by invitation only. DDLS PhD students are invited to participate the entire duration […]